Li Xu

Hangzhou, 310053, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Jieduquyuziyin prescription for systemic lupus erythematosus: a system-level therapeutic strategy for immunological recalibration.

Jieduquyuziyin prescription for systemic lupus erythematosus: a system-level therapeutic strategy for immunological recalibration.

Journal: Chinese medicine

Published: November 04, 2025

Gentiopicroside attenuates lupus arthritis by targeting galectin-mediated macrophage activation.

Gentiopicroside attenuates lupus arthritis by targeting galectin-mediated macrophage activation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 19, 2025

Penthorum chinense Pursh extract ameliorates lupus nephritis disease in MRL/lpr mice via the PPARγ/NFκB signaling axis.

Penthorum chinense Pursh extract ameliorates lupus nephritis disease in MRL/lpr mice via the PPARγ/NFκB signaling axis.

Journal: Journal of ethnopharmacology

Published: June 10, 2025

Identification of lipid metabolism-associated biomarkers in lupus nephritis by SVM model and therapeutic potential of Alisol B 23-acetate.

Identification of lipid metabolism-associated biomarkers in lupus nephritis by SVM model and therapeutic potential of Alisol B 23-acetate.

Journal: Gene

Published: April 11, 2025

Network toxicological and single-cell sequencing reveals the potential mechanisms of psoriatic toxicity of polybrominated diphenyl ethers.

Network toxicological and single-cell sequencing reveals the potential mechanisms of psoriatic toxicity of polybrominated diphenyl ethers.

Journal: Ecotoxicology and environmental safety

Published: December 19, 2024

Potential of CETP inhibition in treating dyslipidemia in systemic lupus erythematosus: Novel and comprehensive evidence from clinical studies and Mendelian randomization.

Potential of CETP inhibition in treating dyslipidemia in systemic lupus erythematosus: Novel and comprehensive evidence from clinical studies and Mendelian randomization.

Journal: International immunopharmacology

Published: November 27, 2024

Sedentary lifestyle, physical activity, and aging: evidence from genetic correlation and mendelian randomization.

Sedentary lifestyle, physical activity, and aging: evidence from genetic correlation and mendelian randomization.

Journal: Aging clinical and experimental research

Published: November 17, 2024

Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis.

Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis.

Journal: Autoimmunity reviews

Published: October 14, 2024

Apigenin ameliorates lupus nephritis by inhibiting SAT3 signaling in CD8+ T cells.

Apigenin ameliorates lupus nephritis by inhibiting SAT3 signaling in CD8+ T cells.

Journal: Food & function

Published: September 16, 2024

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth.

Downregulation of 4-HNE and FOXO4 collaboratively promotes NSCLC cell migration and tumor growth.

Journal: Cell death & disease

Published: February 12, 2024

IGF2BP1 enhances the stability of SIK2 mRNA through m6A modification to promote non-small cell lung cancer progression.

IGF2BP1 enhances the stability of SIK2 mRNA through m6A modification to promote non-small cell lung cancer progression.

Journal: Biochemical and biophysical research communications

Published: June 16, 2023

Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via HIF-1α pathway.

Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via HIF-1α pathway.

Journal: European journal of pharmacology

Published: April 27, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026